Search

A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy™).

… Thursday, March 8, 2012 A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy

Learn how polycystic ovary syndrome (PCOS) may be linked to increased risk of pancreatic cancer.

… Thursday, October 6, 2022 Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects 1 in 10 women of childbearing age. A study suggests PCOS may be associated with as much as double the risk of pancreatic cancer . Memorial Sloan Kettering Cancer Center (MSK) epidemiologist Mengmeng “Margaret

Learn from the MSK President/CEO and Chair of the Board of Trustees about some of the most important advances in cancer care and science at MSK in 2024.

… Friday, June 6, 2025 The year 2024 will be remembered for the bold and strategic course we set to fulfill our mission of ending cancer for life. The need to plan for the future is urgent, as the Centers for Disease Control and Prevention (CDC) predicts the number of people with cancer is expected to

Memorial Sloan Kettering Cancer Center (MSK) continues to enhance patient care, as well as build on our leadership and dedication to conquering cancer, by utilizing the latest technology. MSK’s newly opened Center for Laboratory Medicine on East 64th Street manages almost 2 million specimens and generating approximately 10 million test results per year for all of MSK’s facilities across New York and New Jersey. For more information and to set up interviews or access photos, email [email protected].

… Wednesday, January 10, 2018 Memorial Sloan Kettering Cancer Center (MSK) continues to enhance patient care, as well as build on our leadership and dedication to conquering cancer, by utilizing the latest technology. MSK’s newly opened Center for Laboratory Medicine on East 64th Street manages almost

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.

… Thursday, December 1, 2011 Summary Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain. In his January 1971 State of the Union address, President Richard Nixon officially declared a war on cancer, asking Congress

Students from Manhattan’s Urban Academy Laboratory School paid a visit to Marcel van den Brink’s lab at MSK.

… Friday, March 30, 2018 Summary A group of New York City high school students took a field trip to a lab at Memorial Sloan Kettering.  On Thursday, 16 students from the Urban Academy Laboratory School in Manhattan got a taste of what it’s like to do science in a modern cancer laboratory. Memorial Sloan

ATLANTA, June 5, 2006 - A new multicenter study is the first to suggest that the prophylactic removal of the ovaries and fallopian tubes may provide a different benefit for women who carry a genetic mutation in the BRCA2 gene than for those who have a BRCA1 genetic mutation. The results of the study, which are being presented today at the annual American Society of Clinical Oncology meeting, also provide the strongest evidence to date that this surgery significantly reduces the overall risk of BRCA-associated breast and ovarian cancers.

… Monday, June 5, 2006 A new multicenter study is the first to suggest that the prophylactic removal of the ovaries and fallopian tubes may provide a different benefit for women who carry a genetic mutation in the BRCA2 gene than for those who have a BRCA1 genetic mutation. The results of the study, which

Learn how a clinical trial for a new type of immunotherapy called TCR therapy benefited a patient with synovial sarcoma.

… Wednesday, July 16, 2025 It was hard enough the first time Conor Handley was diagnosed with cancer, at age 17. He had a rare soft tissue cancer called synovial sarcoma. Then three years after finishing treatment, early in his senior year of college, came the devastating news: His synovial sarcoma was

Learn how molecular analysis of Jason’s sarcoma led to a personalized immunotherapy treatment that dramatically improved his prognosis. MSK is a leader in treating sarcoma.

… Monday, July 18, 2022 Thirty-four-year-old Jason Mascolo put off getting the nagging pain in his leg checked out for years because he didn’t have health insurance. It wasn’t until he got a job with benefits — as a utility worker with Consolidated Edison — that he went to see a doctor. The news was not

Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.

… Thursday, October 1, 2009 Summary Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer. Results from studies in cell cultures and mouse models suggest that the experimental